Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
ARWR holding history
Arrowhead Pharmaceuticals, Inc. in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −11,660−100.0% | Sold out | Holders |
| Q3 2023 | 11,660 | $313.3K | <0.1% | −2,380−17.0% | Reduced | Holders |
| Q2 2023 | 14,040 | $500.7K | <0.1% | −450−3.1% | Reduced | Holders |
| Q1 2023 | 14,490 | $368.0K | <0.1% | −569−3.8% | Reduced | Holders |
| Q4 2022 | 15,059 | $610.8K | <0.1% | −1,870−11.0% | Reduced | Holders |
| Q3 2022 | 16,929 | $560.0K | <0.1% | −3,005−15.1% | Reduced | Holders |
| Q2 2022 | 19,934 | $702.0K | <0.1% | −385−1.9% | Reduced | Holders |
| Q1 2022 | 20,319 | $934.0K | <0.1% | −300−1.5% | Reduced | Holders |
| Q4 2021 | 20,619 | $1.37M | <0.1% | −83−0.4% | Reduced | Holders |
| Q3 2021 | 20,702 | $1.29M | <0.1% | −212−1.0% | Reduced | Holders |
| Q2 2021 | 20,914 | $1.73M | <0.1% | −304−1.4% | Reduced | Holders |
| Q1 2021 | 21,218 | $1.41M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.